We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NAT:NYSENordic American Tankers Limited Analysis

Data as of 2026-05-31 - not real-time

$5.15

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Nordic American Tankers is trading at $5.15, comfortably above its DCF‑derived fair value of $4.46 and far above the industry average P/E of 20, indicating a potentially overvalued stock. The company boasts an eye‑catching dividend yield of 17.09% and a modest payout ratio, yet free cash flow is negative and debt‑to‑equity sits at an alarming 91, raising questions about dividend sustainability. Recent contract wins have lifted vessel utilization to $68,000 per day in Q2, up from $47,600 in Q1, supporting near‑term revenue, but the broader energy midstream sector remains volatile amid Middle‑East tensions. Technical signals are mixed: RSI at 36 hints at slight oversold conditions, while a bearish MACD and price hovering just above the $5.02 support level suggest limited upside in the short run.
Given the high volatility (36% 30‑day), low beta (0.22), and a neutral trend, investors should weigh the generous dividend against the company’s cash‑flow strain and elevated leverage before making a move.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support with bearish MACD
  • High dividend yield but questionable cash‑flow backing
  • Increasing volume suggests some buying interest

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Improved vessel utilization rates supporting revenue
  • Elevated leverage and negative free cash flow
  • Valuation still above fair value despite modest upside potential

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Persistent overvaluation relative to fundamentals
  • High debt load and limited earnings growth
  • Dividend sustainability concerns amid cash‑flow weakness

Key Metrics & Analysis

Financial Health

Revenue Growth109.00%
Profit Margin16.27%
P/E Ratio85.8
ROE11.36%
ROA4.84%
Debt/Equity91.11
P/B Ratio2.4
Op. Cash Flow$50.4M
Free Cash Flow$-98511248
Industry P/E20.5

Technical Analysis

TrendNeutral
RSI36.6
Support$5.02
Resistance$6.02
MA 20$5.57
MA 50$5.67
MA 200$4.27
MACDBearish
VolumeIncreasing
Fear & Greed Index94.07

Valuation

Fair Value$4.46
Target Price$6.00
Upside/Downside16.50%
GradeOvervalued
TypeValue
Dividend Yield17.09%

Risk Assessment

Beta0.22
Volatility36.22%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.